Alternatively, a European Medicines Agency approved drug Tafamidis or Vyndaqel now exists which stabilizes transthyretin tetramers comprising wild type and different mutant subunits against amyloidogenesis halting the progression of peripheral neuropathy and autonomic nervous system dysfunction.
Peripheral neuropathy | neuropathy | Familial dysautonomia | Beta amyloid | Radial neuropathy | Kjer's optic neuropathy | Familial hypercholesterolemia | Familial Alzheimer's Disease | familial | Diabetic neuropathy | beta amyloid |